Fondo Bibliografico Internacional Julio-Agosto 2006
Enfermedad hepática alcohólica, hígado
graso y esteatohepatitis no alcohólica
In vivo assessment of liver cell apoptosis as a novel biomarker
of disease severity in nonalcoholic fatty liver disease. Wieckowska A, Zein
NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. Hepatology 2006;44:27-33.
Interés de la determinación de la caspasa
circulante para el diagnóstico de la esteatohepatitis no alcohólica.
Gender, fatty liver and GGT. Carulli L, Lonardo A, Lombardini
S, Marchesini G, Loria P. Hepatology 2006;44:278-9.
Carta.
Enlarged hepatocytes in NAFLD examined with osmium fixation:
does microsteatosis underlie cellular ballooning in NASH? Caldwell SH, Redick
JA, Chang CY, Davis CA, Argo CK, Al Osaimi KA. American Journal of Gastroenterology
2006;101:1677-8.
Carta.
Age and gender relationships of serum alanine aminotransferase
values in healthy subjects. Grossi E, Colombo R, Cavuto S, Franzini C. American
Journal of Gastroenterology 2006;101:1675-6.
Carta.
Aspartate aminotransferase to platelet ratio index in patients
with alcoholic liver fibrosis. Lieber CS, Weiss DG, Morgan TR, Paronetto F.
American Journal of Gastroenterology 2006;101:1500-8.
Utilidad limitada del índice APRI para predecir
la extensión de la fibrosis hepática alcohólica.
Conservation of whole body nitric oxide metabolism in human
alcoholic liver disease: implications for nitric oxide production. Demoncheaux
EA, Elphick DA, Durner MB, Higgins GE, Crowther D, Williams EJ, Higenbottam
TW, Gleeson D. Scandinavian Journal of Gastroenterology 2006;41:820-5.
Se cuestiona el interés del metabolismo del
óxido nítrico en la hepatopatía alcohólica.
Statins and hepatic steatosis: Perspectives from the Dallas
Heart Study. Browning JD. Hepatology 2006;44:466-71.
Ausencia de relación entre la administración
de estatinas y la presencia de esteatosis hepática, ni tampoco con
aumento de las transaminasas.
NAFLD in children: A prospective clinical-pathological study
and effect of lifestyle advice. Nobili V, Marcellini M, Devito R, Ciampalini
P, Piemonte F, Comparcola D, Sartorelli MR, Angulo P. Hepatology 2006;44:458-65.
Resistencia a la insulina independiente del índice
de masa corporal en los niños con esteatohepatitis no alcohólica.
The inflammatory C-reactive protein is increased in both liver
and adipose tissue in severely obese patients independently from metabolic
syndrome, Type 2 diabetes, and NASH. Anty R, Bekri S, Luciani N, Saint-Paul
MC, Dahman M, Iannelli A, Amor IB, Staccini-Myx A, Huet PM, Gugenheim J, Sadoul
JL, Le Marchand-Brustel Y, Tran A, Gual P. American Journal of Gastroenterology
2006;101:1824-33.
La proteína C reactiva no es útil para
el diagnóstico de esteatohepatitis no alcohólica en pacientes
obesos.
Ring-shaped appearance in liver-specific image with Levovist:
a characteristic enhancement pattern for hypervascular benign nodule in the
liver of heavy drinkers. Maruyama H, Matsutani S, Kondo F, Yoshizumi H, Kobayashi
S, Okugawa H, Ebara M, Saisho H. Liver International 2006;26:688-94.
Utilidad del contraste ecográfico para distinguir
los nódulos hipervasculares benignos y el carcinoma hepatocelular en
los pacientes alcohólicos.
Increased risk of NASH in patients carrying the C(-159)T polymorphism
in the CD14 gene promoter region. Brun P, Castagliuolo I, Floreani AR, Buda
A, Blasone L, Palu G, Martines D. Gut 2006;55:1212.
Carta.
Intrahepatic gene expression in human alcoholic hepatitis.
Seth D, Gorrell MD, Cordoba S, McCaughan GW, Haber PS. Journal of Hepatology
2006;45:306-20.
Perfil de expresión génica intrahepática
en pacientes con hepatitis alcohólica.
